<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00690157</url>
  </required_header>
  <id_info>
    <org_study_id>POLKARD 1304/IK-AG-K-283/03</org_study_id>
    <nct_id>NCT00690157</nct_id>
  </id_info>
  <brief_title>Registry of Patients Referred for Heart Transplantation</brief_title>
  <acronym>POLKARD HF</acronym>
  <official_title>National Polish Registry of Patients Referred for Heart Transplantation. POLKARD HF</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institute of Cardiology, Warsaw, Poland</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ministry of Health, Poland</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Institute of Cardiology, Warsaw, Poland</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Main goal of the study is the risk stratification of patients with advanced heart failure
      referred for orthotopic heart transplantation (OHT) according to HFSS score, other risk
      factors and biological markers and verification of their prognostic value in Polish
      population.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      PART I 23.10.2008- 31.12.2005 Creation of the Polish national registry of patients referred
      for cardiac transplantation and after heart transplantation - including urgency of
      qualification and prognosis.

      Main goal of the study is the risk stratification of patients with advanced heart failure
      referred for orthotopic heart transplantation (OHT) according to HFSS score, other risk
      factors and biological markers and verification of their prognostic value in Polish
      population.

      All patients with advanced heart failure referred as potential candidates for OHT in all
      active transplantation centers were included in the registry.

      PART II 1.01.2006 -30.11.2007 Since 2006 only patients which were definitely enlisted on the
      waiting list for heart transplantation were included in the registry

      Clinical and laboratory data were recorded in the internet based form. Clinical data included
      the etiology of the disease, NYHA class, duration of symptoms pharmacological therapy, left
      ventricular ejection fraction, Ergospirometric maximal oxygen uptake (V02 max) results and
      right heart catheterization results , ecg data of leading heart rhythm and QRS duration
      &gt;=0,12 s and other were stored Sodium ,NTproBNP levels and hs CRP plasma levels were recorded
      during first 48 hours of hospitalization. All patients were followed in a prospective cohort
      study until the end point : death or OHT , observations were censored at the end of the
      study. The urgency of OHT and death data was recorded by information from participating
      centers and national death registry quarries.

      Primary end point : Death for all causes or urgent (UNOS 1) heart transplantation Secondary
      end point: Death without transplantation Death or heart transplantation

      Substudy POLKARD HF registry - genetic polymorphism substudy Study start date 01.04.2004 end
      30.10.2007

      Study population: All consecutive patients included into POLKARD HF registry, who agreed to
      participate and signed ICF related to the substudy.

      Estimated size 350 - 450 patients.

      Aims: To describe the potential impact of selected candidate genes polymorphisms on the heart
      failure prognosis and the survival of patients after orthotropic heart transplantation
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2003</start_date>
  <completion_date type="Actual">October 2007</completion_date>
  <primary_completion_date type="Actual">October 2007</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Death for all causes or urgent heart transplantation</measure>
    <time_frame>prospective progressive 1 to 48 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Death without heart transplantation</measure>
    <time_frame>prospective , progressive 1 to 48 months</time_frame>
  </secondary_outcome>
  <enrollment type="Actual">999</enrollment>
  <condition>Advanced Heart Failure</condition>
  <condition>Heart Transplantation</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      whole blood
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with advanced heart failure referred for orthotropic heart transplantation (OHT)
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  men and women aged &gt;10 years with advanced heart failure

          -  referred as potential candidates for orthotropic heart transplantation

        Exclusion Criteria:

          -  refusal to participate in the registry

          -  not enlisted for heart transplantation (since 2006)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>10 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marian Zembala, MD,PhD, Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>Śląskie Centrum Chorób Serca,Klinika Kardiochirurgii,ul. Szpitalna 2, 41-800 Zabrze</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jerzy Sadowski, MD,PhD, Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>Collegium Medicum Uniwersytetu Jagiellońskiego,Klinika Chirurgii Serca Naczyń i Transplantologii,ul. Prądnicka 80, 31-202 Kraków</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mirosław Garlicki, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Klinika Kardiochirurgii Centralnego Szpitala Klinicznego MSWiA, ul. Wołoska 137, 02-507 Warszawa</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jerzy Korewicki, MD,PhD, Prof</last_name>
    <role>Study Director</role>
    <affiliation>Klinika Niewydolności Serca i Transplantologii, Instytut Kardiologii, 04-628 Warszawa ul.Alpejska 42</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Aldona Browarek, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Klinika Niewydolności Serca i Transplantologii, Instytut Kardiologii, 04-628 Warszawa ul.Alpejska 42</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Klinika Chirurgii Serca, Naczyń i Transplantologii, Szpital im.Jan Pawłą II</name>
      <address>
        <city>Kraków</city>
        <zip>31202</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinika Kardiochirurgii CSK MSWiA</name>
      <address>
        <city>Warszawa</city>
        <zip>02-507</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>II Klinika Kardiochirurgii Instytutu Kardiologii</name>
      <address>
        <city>Warszawa</city>
        <zip>04-628</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinika Niewydolności Serca i Transplantologii Instytutu Kardiologii</name>
      <address>
        <city>Warszawa</city>
        <zip>04-628</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Śląskie Centrum Chorób Serca</name>
      <address>
        <city>Zabrze</city>
        <zip>41-800</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Poland</country>
  </location_countries>
  <results_reference>
    <citation>Korewicki J., Browarek A., Zielinski T., Sobieszczanska-Małek M., Piotrowska M., Zembala M., Zakliczynski M., Rozentryt P., Baranska-Kosakowska A., Sadowski J., Przybyłowski P., Milaniak I., Garlicki M.: Prognosis of patients with advanced heart failure referred for heart transplantation data of POLKARD HF 2003-2005.[Rokowanie chorych z ciężką niewydolnością serca, wstępnie kwalifikowanych do przeszczepu serca - na podstawie danych ogólnopolskiego rejestru POLKARD 2003-2005.] Kardiochir. Torakochir. Pol., 2006(3): 308 - 322.</citation>
  </results_reference>
  <verification_date>September 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 29, 2008</study_first_submitted>
  <study_first_submitted_qc>June 3, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 4, 2008</study_first_posted>
  <last_update_submitted>September 14, 2009</last_update_submitted>
  <last_update_submitted_qc>September 14, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 15, 2009</last_update_posted>
  <responsible_party>
    <name_title>Jerzy Korewicki, MD, Professor</name_title>
    <organization>Institute of Cardiology Warsaw, Poland</organization>
  </responsible_party>
  <keyword>heart failure, prognosis, markers,heart transplantation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

